Let me try to clarify it a bit here. When the proxy

New Post Public Reply Private Reply Replies (0) Message Board
BruceLake lodge #15477
878
Let me try to clarify it a bit here. When the proxy statement was initially issued on July 22, there was no mention of an Authorized Share increase.

https://www.sec.gov/Archives/edgar/data/14319...re-14a.htm

We immediately notified Ziv and made him aware that the court order required the company to hold a meeting and to allow shareholders to vote on a proposal for not only a Reverse Split but also for an Authorized Share increase. On July 27. the proxy statement was amended accordingly.

https://www.sec.gov/Archives/edgar/data/14319...er-14a.htm

On Friday Sept. 4, the proxy statement makes it clear that the company is seeking an and/or outcome for proposals #1 and #2.

https://www.sec.gov/Archives/edgar/data/14319...efa14a.htm

On August 31 – September 1,, 2020, we attempted to convene a Special Meeting of shareholders to (i) authorize the Company’s Board of Directors to effect a reverse stock split of the Company’s outstanding Common Stock, $0.00001 par value per share, at any ratio between 1-for-10 and 1-for-20 at such time, prior to September 7, 2020, as the Company’s Board of Directors shall determine, in its sole discretion (“Proposal No. 1”), (ii) amend the Company’s Certificate of Incorporation to increase the number of the Company’s authorized shares of Common Stock from 500,000,000 shares to 2,500,000,000 shares (“Proposal No. 2”) and (iii) to approve one or more adjournments to the meeting, if necessary or appropriate, to permit further solicitation of proxies if there are not sufficient votes at the time of the Meeting cast in favor of Proposals No. 1 and/or No. 2 (“Proposal No. 3”).

Ziv made this clear in the meeting as well that he will be fine with any outcome as long as the outcome gives the company room to move forward. He also mentioned in a conversation that as soon as they reach a quorum they will bring the vote to an end.

So far it would appear that shareholders who care about the company's future are voting for at least one of #1 and #2.

For what it's worth I voted AGAINST / FOR / FOR.

At this point I don't even want to contemplate what will happen if shareholders don't approve at least one of the proposals. In my view it guarantees that we will live for another day, and I'm also optimistic that Ziv has the connections and what it takes to turn this company around...along with our fortunes.




OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cardinal Health Surges with Increased EPS Outlook

Updated Category News Views 132

Cardinal Health's Towering Numbers and Raised Outlook Holy moly, Cardinal Health is strutting out of the gate like they mean business. Their first quarter for fiscal year 2027 showed revenue hitting a hefty $67.5 billion—up 5% from last year. If you're holding NYSE:CAH, you might be grinning ear to ear right now. Cardinal didn’t just squeeze out more revenue; they saw...

Continue Reading
Changshan's Tourism Boom: 22.8% Increase Over Holiday

Updated Category News Views 94

Changshan Grabs Attention This National Day You know, I blinked twice when I saw Changshan's tourist numbers this year. During the 2026 National Day holiday, they managed to snag 503,000 visitors. That's up by a whopping 22.8% from last year. If that doesn't grab your attention, I don't know what will. We're talking record numbers here, folks, and that's the kind of...

Continue Reading
PureCycle's 12% Drop: What's Next for Investors?

Updated Category News Views 29

In the Crosshairs: PureCycle's Tumble Nothing kicks off investor chatter like a jarring 12% dive in share value. PureCycle Technologies (NASDAQ: PCT) gave us just that when they aired their dirty laundry—operational hiccups and a not-so-friendly regulatory dance cost them big in the latest quarter. Now, if you've got skin in the PCT game, you're likely eyeing every...

Continue Reading
Sae-A Trading Earns UNGC LEAD Recognition Again

Updated Category News Views 122

Another Year, Another Win for Sae-A Trading When was the last time you heard of an apparel manufacturer making waves for the right reasons? Sae-A Trading, the outfit under the Global Sae-A Group banner, is strutting its sustainability stuff by getting named as a UNGC LEAD Company for the second straight year. You better believe that’s not just for show – they’ve got...

Continue Reading
METLEN Posts Record 9-Month Revenue in 2026

Updated Category News Views 132

Record Revenue Achievement Oh boy, METLEN just broke the bank with its nine-month trading update for 2026, hitting €6.2 billion in revenue. It's the highest they've ever seen for this period. A 21% jump from the previous €5.1 billion in 9M2025—now that's saying something in these unpredictable markets. Drilling down, the company’s business units showed they can...

Continue Reading
BVB, SPORTFIVE Lock Partnership Until 2034; Sparks Fly

Updated Category News Views 111

Sealing the Deal with Strategic Long-term Goals Alright, here’s the scoop straight outta Dortmund. Borussia Dortmund and SPORTFIVE have penned themselves a cushy deal lasting till 2034. That’s right—eight more solid years. Talk about shuffling the deck with some planning foresight, huh? Been hitting shoulders since '99, these two, so this ain’t just another...

Continue Reading
NORROY's Radiopharma Innovations: EANM Highlights

Updated Category News Views 107

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

Continue Reading
Ecovyst Ups Outlook Amid Strong Q3 Results

Updated Category News Views 115

A Bold Leap Forward Ecovyst, mighty in the sulfuric acid trade, just dropped news hotter than a griddle on a sizzling morning. Sales surged by 51% in Q3 to a solid $308.6 million, credited to smart moves and timely acquisitions. Not just puffery here; these folks are redirecting the narrative and it's showing in the numbers. Imagine a company selling parts of itself to...

Continue Reading
Co-Diagnostics Moves Up Q3 Earnings Release to Nov. 10

Updated Category News Views 95

Co-Diagnostics Shifts Its Calendar Well, well, well, Co-Diagnostics decided to shake up its calendar. What are they looking to spill before the weekend? They’ve bumped up their third quarter 2026 earnings release by two days—an eyebrow-raiser for folks watching NASDAQ:CODX. Now they'll lay it all out on November 10, after we wrap up the trading day. I don’t want to...

Continue Reading
Wheels Up Expands Fleet with New Phenom 300E Jets

Updated Category News Views 70

Wheels Up's New Horizons with Phenom 300E Jets Wheels Up Experience Inc. (NYSE: UP) just dropped a bombshell with their plan to purchase six spanking new Phenom 300E jets from Embraer (NYSE: EMBJ). This ain't just another lease agreement; this is their first-ever direct buy from Embraer, and it's set to add some serious flair to their fleet. Setting the Stage for Growth...

Continue Reading

Top 5 Most Recently Viewed Articles

Ultimo Expands Its U.S. Presence with Strategic Acquisition

Updated Category News Views 236

Ultimo's Significant Step Forward in U.S. Market Ultimo, a notable name in AI-augmented enterprise asset management, has taken a bold step forward in its growth journey by acquiring FSI, a company famed for its pioneering contributions to healthcare technology management. This acquisition highlights Ultimo’s commitment to enhancing its offerings in the United States and...

Continue Reading
Karmanos Cancer Institute Strengthens Team with New Expert

Updated Category News Views 137

New Addition to Karmanos Cancer Institute's Team José Larios, M.D., a specialized transplant hematologist, has recently joined the Barbara Ann Karmanos Cancer Institute. This institution is recognized for its comprehensive programs aimed at treating various hematologic conditions, including different types of blood cancers like leukemia and lymphoma. Expertise in Blood...

Continue Reading
Revolutionary Features of Signia Pure Charge&Go BCT IX Hearing Aids

Updated Category News Views 217

Introducing the Signia Pure Charge&Go BCT IX Hearing Aids Signia has launched the much-anticipated Pure Charge&Go BCT IX hearing aids, and they are making waves in the hearing aid industry. These new hearing aids bring remarkable advancements in battery life, sound quality, and connectivity. For anyone looking for a reliable and efficient hearing aid, the Pure Charge&Go...

Continue Reading
Highlights from the Extraordinary General Assembly of RIAS A/S

Updated Category News Views 64

Overview of the Extraordinary General Assembly The Extraordinary General Assembly (EGA) of RIAS A/S attracted considerable interest as shareholders gathered to address vital corporate matters. This assembly provided a platform for stakeholders invested in the future of RIAS A/S, ensuring everyone had a chance to share their thoughts. Key Decisions Made During the...

Continue Reading
Celebrating Entrepreneurship at Palm Beach Atlantic University

Updated Category News Views 267

Honoring Excellence in Entrepreneurship As Palm Beach Atlantic University (PBA) prepares for its annual American Free Enterprise Day (AFE), the excitement among the community is palpable. This event, a highlight of the year in Palm Beach County, celebrates the spirit of entrepreneurship and the remarkable achievements of its leaders. This year’s celebration will...

Continue Reading